Search Login Register

Hyperplasia Summary

Description: An increase in the number of cells in a tissue or organ without tumor formation. It differs from HYPERTROPHY, which is an increase in bulk without an increase in the number of cells.

Also Known As: Hyperplasias

Networked: 20866 relevant articles (632 outcomes, 1837 trials/studies) for this Disease

Key Drugs and Agents for Hyperplasia

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Sirolimus (Rapamycin) : 20 outcomes 34 studies in 145 results : FDA 2
  2. Aldosterone : 15 outcomes 31 studies in 359 results : IBA
  3. Insulin (Novolin) : 15 outcomes 16 studies in 276 results : FDA 2
  4. Glucose (Dextrose) : 14 outcomes 7 studies in 124 results : FDA 175 Generic
  5. Dexamethasone (Maxidex) : 13 outcomes 14 studies in 102 results : FDA 77 Generic
  6. Adrenocorticotropic Hormone (ACTH) : 10 outcomes 27 studies in 490 results : FDA 7
  7. glucuronyl glucosamine glycan sulfate (Vessel) : 10 outcomes 19 studies in 400 results : IBA
  8. 1-phenyl-3,3-dimethyltriazene (PDT) : 10 outcomes 17 studies in 48 results : IBA
  9. DNA (Deoxyribonucleic Acid) : 8 outcomes 45 studies in 596 results : IBA
  10. Paclitaxel (Taxol) : 8 outcomes 24 studies in 89 results : FDA 13 Generic
Show All >>

Diseases Related to Hyperplasia

  1. Adenoma (Adenomas)
  2. Neoplasms (Cancer)
  3. Hypertrophy
  4. Pathologic Constriction (Stenosis)
  5. Hyperaldosteronism (Conn Syndrome)
Show All >>

Key Therapies for Hyperplasia

Efficacy Chart >>
  1. Stents : 78 outcomes 196 studies in 1121 results
  2. Transplants (Transplant) : 66 outcomes 178 studies in 1447 results
  3. Adrenalectomy : 20 outcomes 5 studies in 170 results
  4. Angioplasty (Angioplasty, Transluminal) : 19 outcomes 21 studies in 250 results
  5. Thymectomy : 10 outcomes 3 studies in 48 results
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.